X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33) 33
index medicus (28) 28
clinical neurology (22) 22
pediatrics (22) 22
male (21) 21
child (20) 20
female (19) 19
neurology (19) 19
children (16) 16
adolescent (12) 12
child, preschool (11) 11
medicine and health sciences (9) 9
epilepsy (8) 8
infant (7) 7
magnetic resonance imaging (7) 7
adult (6) 6
childhood (6) 6
encephalitis (6) 6
retrospective studies (6) 6
seizures (6) 6
treatment outcome (6) 6
genetics (5) 5
neurosciences (5) 5
phenotype (5) 5
research (5) 5
young adult (5) 5
abridged index medicus (4) 4
anticonvulsants - therapeutic use (4) 4
disease (4) 4
human medicine (4) 4
infantile spasms (4) 4
mutation (4) 4
onset (4) 4
surgery (4) 4
adrenocorticotropic hormone - therapeutic use (3) 3
analysis (3) 3
biology and life sciences (3) 3
diagnosis (3) 3
disease progression (3) 3
drug therapy (3) 3
epilepsy - drug therapy (3) 3
genes (3) 3
health aspects (3) 3
medical research (3) 3
medicine, experimental (3) 3
medicine, research & experimental (3) 3
middle aged (3) 3
mutation - genetics (3) 3
mutations (3) 3
therapy (3) 3
227 (2) 2
adults (2) 2
age (2) 2
alleles (2) 2
angiomyolipoma (2) 2
animals (2) 2
anti-epileptic drugs (2) 2
antibodies (2) 2
article (2) 2
astrocytoma (2) 2
atrophy (2) 2
attention deficit disorder with hyperactivity - drug therapy (2) 2
attention deficit disorder with hyperactivity - psychology (2) 2
attention-deficit hyperactivity disorder (2) 2
belgium (2) 2
brain - pathology (2) 2
care and treatment (2) 2
central nervous system (2) 2
cerebrospinal fluid (2) 2
children & youth (2) 2
clinical trials (2) 2
cognition disorders - etiology (2) 2
cognition disorders - psychology (2) 2
consanguinity (2) 2
consent (2) 2
defect (2) 2
deoxyribonucleic acid--dna (2) 2
developmental regression (2) 2
diagnosis, differential (2) 2
disability (2) 2
disorders (2) 2
dna mutational analysis (2) 2
double-blind (2) 2
double-blind method (2) 2
drug dosages (2) 2
efficacy (2) 2
electroencephalography (2) 2
encephalopathy (2) 2
epilepsy - etiology (2) 2
everolimus (2) 2
further section (2) 2
gene (2) 2
gene deletion (2) 2
genetic predisposition to disease - genetics (2) 2
genetics & heredity (2) 2
genomics (2) 2
heterozygote (2) 2
hippocampal atrophy (2) 2
hippocampus (2) 2
hypocretin (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 09/2017, Volume 127, Issue 9, pp. 3543 - 3556
Journal Article
Journal Article
Pediatric Neurology, ISSN 0887-8994, 2013, Volume 48, Issue 2, pp. 135 - 138
Journal Article
Trials, ISSN 1745-6215, 03/2017, Volume 18, Issue 1, pp. 145 - 9
Background: Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity disorder (ADHD), is associated with serious adverse effects... 
Pycnogenol | ADD | ADHD | Oxidative stress | Behaviour | Polyphenols | Catecholamines | Antioxidant | Immunity | MEDICINE, RESEARCH & EXPERIMENTAL | HUMAN HEALTH | MICROBIOTA | PINE BARK EXTRACT | DEFICIT/HYPERACTIVITY DISORDER | CHILDREN | Pycnogenol (R) | GLUTATHIONE | CLINICAL-TRIALS | DISEASE | POLYPHENOLIC EXTRACT | Biomarkers - urine | Humans | Clinical Protocols | Male | Flavonoids - adverse effects | Flavonoids - therapeutic use | Adjuvants, Immunologic - adverse effects | Attention Deficit Disorder with Hyperactivity - metabolism | Central Nervous System Stimulants - therapeutic use | Central Nervous System Stimulants - adverse effects | Time Factors | Female | Surveys and Questionnaires | Child Behavior - drug effects | Adjuvants, Immunologic - therapeutic use | Child | Cytokines - blood | Attention Deficit Disorder with Hyperactivity - immunology | Double-Blind Method | Feeding Behavior | Treatment Outcome | Methylphenidate - adverse effects | Biomarkers - blood | Attention Deficit Disorder with Hyperactivity - drug therapy | Antioxidants - therapeutic use | Belgium | Methylphenidate - therapeutic use | Attention Deficit Disorder with Hyperactivity - psychology | Face - microbiology | Antioxidants - adverse effects | Oxidative Stress - drug effects | Research Design | Usage | Analysis | Attention-deficit hyperactivity disorder | Clinical trials | Research | Drug therapy
Journal Article
BMC Neurology, ISSN 1471-2377, 08/2016, Volume 16, Issue 1, p. 126
Journal Article
European Journal of Paediatric Neurology, ISSN 1090-3798, 2017, Volume 21, pp. e49 - e49
Journal Article
European Journal of Paediatric Neurology, ISSN 1090-3798, 2017, Volume 21, pp. e112 - e112
Journal Article
Neurology, ISSN 0028-3878, 2016, Volume 86, Issue 10, pp. 954 - 962
Journal Article
Trials, ISSN 1745-6215, 2017, Volume 18
Background: Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity disorder (ADHD), is associated with serious adverse effects... 
Journal Article
European Journal of Paediatric Neurology, ISSN 1090-3798, 01/2019, Volume 23, Issue 1, pp. 222 - 227
Arterial ischemic stroke is rare in childhood. Often, the diagnosis is made after considerable delay. A thorough workup to pinpoint the underlying etiology is... 
Primary angiitis of the central nervous system | Mycophenolate mofetil | Arterial ischemic stroke | Childhood | PEDIATRICS | CENTRAL-NERVOUS-SYSTEM | PRIMARY ANGIITIS | MECHANISMS | CLINICAL NEUROLOGY
Journal Article
Journal Article
by Koczkowska, Magdalena and Chen, Zhenbin and Chen, Yunjia and Callens, Tom and Gomes, Alicia and Sharp, Angela and Johnson, Sherrell and Hsiao, Meng-Chang and Balasubramanian, Meena and Barnett, Christopher P and Becker, Troy A and Ben-Shachar, Shay and Bertola, Debora R and Blakeley, Jaishri O and Burkitt-Wright, Emma M.M and Callaway, Alison and Crenshaw, Melissa and Cunha, Karin S and Cunningham, Mitch and D’Agostino, Maria D and Dahan, Karin and De Luca, Alessandro and Destrée, Anne and Dhamija, Radhika and Eoli, Marica and Evans, D. Gareth R and Galvin-Parton, Patricia and George-Abraham, Jaya K and Gripp, Karen W and Guevara-Campos, Jose and Hanchard, Neil A and Hernández-Chico, Concepcion and Immken, LaDonna and Janssens, Sandra and Jones, Kristi J and Keena, Beth A and Kochhar, Aaina and Liebelt, Jan and Martir-Negron, Arelis and Mahoney, Maurice J and Maystadt, Isabelle and McDougall, Carey and McEntagart, Meriel and Mendelsohn, Nancy and Miller, David T and Mortier, Geert and Morton, Jenny and Pappas, John and Plotkin, Scott R and Pond, Dinel and Rosenbaum, Kenneth and Rubin, Karol and Russell, Laura and Rutledge, Lane S and Saletti, Veronica and Schonberg, Rhonda and Schreiber, Allison and Seidel, Meredith and Siqveland, Elizabeth and Stockton, David W and Trevisson, Eva and Ullrich, Nicole J and Upadhyaya, Meena and van Minkelen, Rick and Verhelst, Helene and Wallace, Margaret R and Yap, Yoon-Sim and Zackai, Elaine and Zonana, Jonathan and Zurcher, Vickie and Claes, Kathleen and Martin, Yolanda and Korf, Bruce R and Legius, Eric and Messiaen, Ludwine M
The American Journal of Human Genetics, ISSN 0002-9297, 01/2018, Volume 102, Issue 1, pp. 69 - 87
Journal Article
Journal of Child Neurology, ISSN 0883-0738, 11/2005, Volume 20, Issue 11, pp. 911 - 913
Journal Article
Neurology, ISSN 0028-3878, 05/2019, Volume 92, Issue 22, pp. e2538 - e2549
OBJECTIVEThe impetus for this consensus discussion was to recommend clinical trial designs that can deliver high-quality data for effective therapies for... 
UNITED-STATES | RELAPSE | REVISIONS | MULTIPLE-SCLEROSIS | DETERMINANTS | NATALIZUMAB | DIGIT MODALITIES TEST | INTERFERON BETA-1A | ONSET | CLINICAL NEUROLOGY | CHILDREN | 227
Journal Article